Neuroprotective therapy for acute ischaemic stroke: down, but not out.
Publication
, Journal Article
Goldstein, LB
Published in: Lancet
February 7, 2004
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
February 7, 2004
Volume
363
Issue
9407
Start / End Page
414 / 415
Location
England
Related Subject Headings
- Treatment Outcome
- Stroke
- Research Design
- Randomized Controlled Trials as Topic
- Neuroprotective Agents
- Magnesium Sulfate
- Humans
- General & Internal Medicine
- Acute Disease
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B. (2004). Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet, 363(9407), 414–415. https://doi.org/10.1016/S0140-6736(04)15522-0
Goldstein, Larry B. “Neuroprotective therapy for acute ischaemic stroke: down, but not out.” Lancet 363, no. 9407 (February 7, 2004): 414–15. https://doi.org/10.1016/S0140-6736(04)15522-0.
Goldstein LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 7;363(9407):414–5.
Goldstein, Larry B. “Neuroprotective therapy for acute ischaemic stroke: down, but not out.” Lancet, vol. 363, no. 9407, Feb. 2004, pp. 414–15. Pubmed, doi:10.1016/S0140-6736(04)15522-0.
Goldstein LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 7;363(9407):414–415.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
February 7, 2004
Volume
363
Issue
9407
Start / End Page
414 / 415
Location
England
Related Subject Headings
- Treatment Outcome
- Stroke
- Research Design
- Randomized Controlled Trials as Topic
- Neuroprotective Agents
- Magnesium Sulfate
- Humans
- General & Internal Medicine
- Acute Disease
- 42 Health sciences